This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, K.-P. Articles by Daniels, L. Search for Related Content PubMed PubMed Citation Articles by Choi, K.-P. Articles by Daniels, L.

 Previous Article  |  Next Article 

Journal of Bacteriology, May 2002, p. 2420-2428, Vol. 184, No. 9
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.9.2420-2428.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Demonstration that fbiC Is Required by Mycobacterium bovis BCG for Coenzyme F₄₂₀ and FO Biosynthesis

Department of Microbiology, University of Iowa, Iowa City, Iowa 52242

Received 14 November 2001/ Accepted 8 February 2002

Using the nitroimidazopyran-based antituberculosis drug PA-824 as a selective agent, transposon-generated Mycobacterium bovis strain BCG (M. bovis) mutants that could not make coenzyme F₄₂₀ were identified. Four independent mutants that could not make F₄₂₀ or the biosynthesis intermediate FO were examined more closely. These mutants contained transposons inserted in the M. bovis homologue of the Mycobacterium tuberculosis gene Rv1173, which we have named fbiC. Complementation of an M. bovis FbiC^- mutant with fbiC restored the F₄₂₀ phenotype. These data demonstrate that fbiC is essential for F₄₂₀ production and that FbiC participates in a portion of the F₄₂₀ biosynthetic pathway between pyrimidinedione and FO. Homologues of fbiC were found in all 11 microorganisms that have been fully sequenced and that are known to make F₄₂₀. Four of these homologues (all from members of the aerobic actinomycetes) coded for proteins homologous over the entire length of the M. bovis FbiC, but in seven microorganisms two separate genes were found to code for proteins homologous with either the N-terminal or C-terminal portions of the M. bovis FbiC. Histidine-tagged FbiC overexpressed in Escherichia coli produced a fusion protein of the molecular mass predicted from the M. bovis BCG sequence (95,000 Da), as well as three other histidine-tagged proteins of significantly smaller size, which are thought to be proteolysis products of the FbiC fusion protein.

This article has been cited by other articles:

• Villar, R., Vicente, E., Solano, B., Perez-Silanes, S., Aldana, I., Maddry, J. A., Lenaerts, A. J., Franzblau, S. G., Cho, S.-H., Monge, A., Goldman, R. C. (2008). In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. J Antimicrob Chemother 62: 547-554 [Abstract] [Full Text]  
• Vicente, E., Villar, R., Burguete, A., Solano, B., Perez-Silanes, S., Aldana, I., Maddry, J. A., Lenaerts, A. J., Franzblau, S. G., Cho, S.-h., Monge, A., Goldman, R. C. (2008). Efficacy of Quinoxaline-2-Carboxylate 1,4-Di-N-Oxide Derivatives in Experimental Tuberculosis. Antimicrob. Agents Chemother. 52: 3321-3326 [Abstract] [Full Text]  
• Guerra-Lopez, D., Daniels, L., Rawat, M. (2007). Mycobacterium smegmatis mc2 155 fbiC and MSMEG_2392 are involved in triphenylmethane dye decolorization and coenzyme F420 biosynthesis. Microbiology 153: 2724-2732 [Abstract] [Full Text]  
• Manjunatha, U. H., Lahiri, R., Randhawa, B., Dowd, C. S., Krahenbuhl, J. L., Barry, C. E. III (2006). Mycobacterium leprae Is Naturally Resistant to PA-824.. Antimicrob. Agents Chemother. 50: 3350-3354 [Abstract] [Full Text]  
• Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., Barry, C. E. III (2006). Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103: 431-436 [Abstract] [Full Text]  
• Lenaerts, A. J., Gruppo, V., Marietta, K. S., Johnson, C. M., Driscoll, D. K., Tompkins, N. M., Rose, J. D., Reynolds, R. C., Orme, I. M. (2005). Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models. Antimicrob. Agents Chemother. 49: 2294-2301 [Abstract] [Full Text]